Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT04015375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center,Double-blind,Randomized,Three-arm,Placebo-controlled,Parallel-group Study, Comparing Dapsone Gel,7.5% (Torrent Pharma) to Aczone® Gel,7.5% and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT04015375
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Torrent Pharmaceuticals Limited
- Industry
- Enrollment
- 1,150 participants
Conditions and interventions
Conditions
Interventions
- Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) Drug
- ACZONE® (dapsone) gel, 7.5% (Allergan, INC.) Drug
- Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) Other
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 10, 2019
- Primary completion
- Feb 2, 2020
- Completion
- Feb 21, 2020
- Last update posted
- Apr 1, 2020
2019 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Unison Center for Clinical Trials | Sherman Oaks | California | 91403 | — |
| MOORE Clinical Research, Inc. | Brandon | Florida | 33511 | — |
| FXM Clinical Research Miami | Miami | Florida | 33175 | — |
| FXM Clinical Research Miramar | Miramar | Florida | 33027 | — |
| MOORE Clinical Research, Inc. (S. Tampa Site) | Tampa | Florida | 33609 | — |
| MOORE Clinical Research, Inc. (Temple Terrace Site) | Temple Terrace | Florida | 33617 | — |
| Research Institute of Central Florida | Winter Park | Florida | 72792 | — |
| Dermatology Consulting Services, PLLC | High Point | North Carolina | 27262 | — |
| PEAK Research, LLC | Upper Saint Clair | Pennsylvania | 15241 | — |
| 3A Research, LLC - WEST | El Paso | Texas | 79902 | — |
| 3A Research, LLC - EAST | El Paso | Texas | 79925 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04015375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04015375 live on ClinicalTrials.gov.